PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 2, 2024Cancer Research23 citations

Abstract PS08-03: Sequencing Antibody-Drug Conjugate after Antibody-Drug Conjugate in Metastatic Breast Cancer (A3 study): Multi-Institution Experience and Biomarker Analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

RARachel O. AbelmanLSLaura M. SpringGFGeoffrey Fell

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Abelman et al. (2024) studied this question.

synapsesocial.com/papers/68e6bbd2b6db64358763c9e5https://doi.org/10.1158/1538-7445.sabcs23-ps08-03
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract PO3-05-14: Practice patterns for sequential use of antibody-drug conjugate after antibody-drug conjugate in metastatic breast cancer: results from a physician survey2024 · 1 citations
  2. 2Abstract PD3-09: Molecular characterization of resistance to antibody drug conjugates in metastatic breast cancer: a prospective analysis from the AURORA US Network2026
  3. 3Optimal Sequential Strategies for Antibody-Drug Conjugate in Metastatic Breast Cancer: Evaluating Efficacy and Cross-Resistance2024 · 44 citations
  4. 4Sequential use of antibody-drug conjugates in advanced breast cancer: A real-world study based on HER2 status.2026
  5. 5Abstract PS1-09-18: Efficacy of antibody drug conjugates in patients with advanced metaplastic breast cancer: a multi-institutional retrospective cohort study2026